VERTEX PHARMACEUTICALS INC (VRTX)       320.5  -0.95 (-0.3%)

320.5  -0.95 (-0.3%)

US92532F1003 - Common Stock

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
8.70B7.57B6.21B4.16B3.05B
Non Recurring Items
-3.50M3.10M-13.10M-4.50M-28.80M
Minority Interest Expense
N/AN/A0.000.009.80M
Cost Of Goods
1.04B904.20M736.30M547.80M409.50M
Gross Profit
7.66B6.67B5.47B3.62B2.64B
Operating Expenses
3.49B3.89B2.60B2.41B1.97B
Operating Income
4.16B2.78B2.87B1.20B664.00M
Interest Expense
-129.50M-39.50M100.30M10.00M-33.50M
Income Before Taxes
4.03B2.73B3.12B1.39B600.20M
Income Tax
753.34M388.30M405.20M218.10M73.10M
Net Income
3.27B2.34B2.71B1.18B2.10B
EBITDA
4.31B2.91B2.98B1.31B736.40M
 
Per Share Data
EPS Diluted Total Ops
12.679.0110.294.518.09
Non GAAP EPS
14.5013.0210.325.334.09
 
Statistics
Gross Profit Margin
88.00%88.06%88.14%86.84%86.56%
Profit Margin
37.62%30.92%43.70%28.27%68.79%
Operating Profit Margin
47.87%36.73%46.24%28.88%21.79%

All data in USD

Charts